IRIS
BUFO, PANTALEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.473
NA - Nord America 6.467
AS - Asia 3.959
SA - Sud America 237
Continente sconosciuto - Info sul continente non disponibili 26
AF - Africa 16
OC - Oceania 4
Totale 17.182
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.423
CN - Cina 2.232
IE - Irlanda 2.026
UA - Ucraina 1.568
SE - Svezia 916
SG - Singapore 585
RU - Federazione Russa 526
HK - Hong Kong 453
IT - Italia 377
TR - Turchia 343
FI - Finlandia 291
IN - India 272
FR - Francia 251
BR - Brasile 212
DE - Germania 197
GB - Regno Unito 170
CA - Canada 31
AT - Austria 30
CZ - Repubblica Ceca 30
BE - Belgio 29
EU - Europa 24
NL - Olanda 21
IR - Iran 14
ID - Indonesia 9
ES - Italia 8
JP - Giappone 8
CL - Cile 7
MX - Messico 7
RO - Romania 7
EG - Egitto 6
IQ - Iraq 6
AR - Argentina 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
BD - Bangladesh 4
BG - Bulgaria 4
KR - Corea 4
LT - Lituania 4
PK - Pakistan 4
VE - Venezuela 4
ZA - Sudafrica 4
AU - Australia 3
CH - Svizzera 3
PL - Polonia 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CO - Colombia 2
GR - Grecia 2
JO - Giordania 2
LV - Lettonia 2
MA - Marocco 2
MG - Madagascar 2
MK - Macedonia 2
MY - Malesia 2
PE - Perù 2
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BY - Bielorussia 1
CR - Costa Rica 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EE - Estonia 1
GE - Georgia 1
IL - Israele 1
JM - Giamaica 1
KZ - Kazakistan 1
MZ - Mozambico 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
PY - Paraguay 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TN - Tunisia 1
Totale 17.182
Salva come PNG Salva come JPEG
Città #
Dublin 2.025
Jacksonville 1.109
Chandler 953
Dearborn 697
Nanjing 607
Nyköping 575
Hong Kong 453
Wilmington 264
Beijing 243
Santa Clara 229
Princeton 222
Nanchang 221
New York 220
San Mateo 206
Singapore 194
Ann Arbor 185
Ashburn 160
Shenyang 151
Moscow 133
Boardman 107
Woodbridge 101
The Dalles 95
Tianjin 91
Hebei 85
Jiaxing 85
Kunming 83
Helsinki 80
Jinan 70
Des Moines 64
Changsha 62
Hangzhou 58
Los Angeles 49
Guangzhou 47
Munich 46
Shanghai 45
Hilden 43
Foggia 37
Ningbo 31
Brussels 29
Zhengzhou 29
Vienna 27
Norwalk 25
Lanzhou 22
Strasbourg 22
Taizhou 22
Changchun 21
Seattle 21
Brno 20
Orange 19
Pune 19
London 16
Washington 16
Bari 15
Rome 14
Stevenage 13
São Paulo 13
Hanover 12
Lavagna 12
Milan 12
Auburn Hills 11
Hefei 11
Redwood City 10
Rio de Janeiro 10
Wuhan 10
Belo Horizonte 9
Borås 9
Cedar Knolls 8
Fuzhou 8
Houston 8
Jakarta 8
Nuremberg 8
Olomouc 8
Campinas 7
Ottawa 7
Shenzhen 7
Toronto 7
Napoli 6
Saint Petersburg 6
Salerno 6
Timisoara 6
Chicago 5
Falls Church 5
Florence 5
Haikou 5
Jeddah 5
Paris 5
Rui'an 5
Salvador 5
San Jose 5
Curitiba 4
Molfetta 4
Philadelphia 4
Ribeirão Preto 4
Shaoxing 4
Sofia 4
Tashkent 4
Turku 4
Xuzhou 4
Betim 3
Bologna 3
Totale 10.782
Salva come PNG Salva come JPEG
Nome #
Wheater ISTOPATOLOGIA ESSENZIALE 206
Altered expression of HER-2 and the mismatch repair genes MLH1 and MSH2 predicts the outcome of T1 high-grade bladder cancer 174
Post-void residual urinary volume is an independent predictor of biopsy results in men at risk for prostate cancer 165
Immunohistochemical expression of CD3, CD20, CD45, CD68 and bcl-2 in oral squamous cell carcinoma. 157
EFFETTI DEL CLORURO DI MERCURIO (HgCl2) SULLA FOSFORILAZIONE DELLA SURVIVINA IN CHERATINOCITI IN COLTURA 141
Expression of β-catenin in human tooth germ. 129
Benign metastasizing leiomyoma of external iliac vessels: an unusual case report. 129
WNT pathway in oral cancer: Epigenetic inactivation of WNT-inhibitors 129
Pentraxin 3: A novel biomarker for predicting progression from prostatic inflammation to prostate cancer 120
Using analytical morphometry to distinguish severe dysplasia and large bowel carcinoma. 116
Absence of bladder outlet obstruction is an independent risk factor for prostate cancer in men undergoing prostate biopsy 114
TRAP1 regulates cell cycle and apoptosis in thyroid carcinoma cells 114
Aberrant DNA hypermethylation of hMLH-1 and CDKN2A/p16 genes in benign, premalignant and malignant endometrial lesions 112
Alternative mRNA splicing of survivin gene in oral squamous cell carcinoma 110
Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma 110
Survivin as prognostic factor in squamous cell carcinoma of the oral cavity 107
p63 overexpression associates with poor prognosis in head and neck squamous cell carcinoma 107
Cyclooxygenase isozymes 1 and 2 in oral squamous cell carcinoma: a real-time RT-PCR study with clinic pathological correlations 107
A central role of P34CDC2-cyclin B1 kinase in survivin phosphorylation during oral cancerogenesis. 106
II ruolo del complesso di attivazione della survivina nelle lesioni pre-cancerose del cavo orale. 105
Bladder Metastases from Breast Cancer: Managing the Unexpected. A Systematic Review 105
Analisi quantitativa dell’espressione genica delle isoforme della ciclossigenasi nella cancerogenesi orale mediante RealTime-PCR 104
"L'importanza della valutazione istologica seriata sulle piaghe da ustione per una definizione del tipo e grado di infezione" 104
Aurora B expression as a prognostic indicator and possibile therapeutic target in oral squamous cell carcinoma. 104
Comparative CDH1 (E-cadherin) analysis by gene expression and epigenetic inactivation in patients affected by oral squamous cell carcinoma (OSCC). Preliminary report 104
A Troubling Diagnosis of Verrucous Squamous Cell Carcinoma ("the Bad Kind" of Keratosis) and the Need of Clinical and Pathological Correlations: A Review of the Literature with a Case Report. 102
Espressione della survivina e della survivina fosforilata in cheratinociti immortalizzati del cavo orale 102
Beta-Catenin and Epithelial Tumors: A Study Based on 374 Oropharyngeal Cancers 101
Investigation of the patterns of argyrophilic nucleolar organiser regions (AgNORs) in primary gastric lymphomas. 100
Survivin expression in renal cell carcinoma 99
Epigenetic inactivation of the WNT-pathway genes in oral squamous cell carcinoma. Preliminary report 99
Altered p53 and pRb expression is predictive of response to BCG treatment in T1G3 bladder cancer 98
Cyclooxygenase-2 expression in oral squamous cell carcinoma 97
Epigenetic silencing of wnt-inhibitors: activation of a constitutive wnt signalling in oral cancer 97
ANALISI DELL’ESPRESSIONE DI POKEMON IN LINEE CELLULARI DI CARCINOMA SQUAMOCELLULARE DEL CAVO ORALE. 96
Urine profiling by SELDI-TOF/MS: Monitoring of the critical steps in sample collection, handling and analysis 96
P-cadherin expression predicts clinical outcome in oral squamous cell carcinomas 95
Intraosseous myoepithelioma of the maxilla: clinicopathologic features and therapeutic considerations. 95
A case of ovarian psammocarcinoma associated with endometrioid cysts: a morphological and immunohistochemical study 95
Urethral corpus spongiosum amyloidosis presenting with urethrorrhagia during erection 95
Aurora-B kinase expression in oral squamous cell carcinoma (OSCC); a preliminary report 95
P16 immunohistochemistry, consensus PCR HPV-DNA, and in situ hybridization: a combined triple method to detect HPV positive oral and oropharyngeal squamous cell carcinomas 94
Epigenetic study of wnt-pathway activation in gastrointestinal cancer: validation of an epigenetic fingerprint as innovative diagnostic tool 94
Role of Runx2 phosphorylation in prostate cancer and association with metastatic disease 94
Regulation of mRNA and protein levels of beta1 integrin variants in human prostate cancer 93
Pelvic mass-like florid cystic endosalpingiosis of the uterus: a case report and a review of literature. 93
Report of a case of discoid lupus erythematosus localised to the oral cavity: immunofluorescence findings 92
Reduced percentage of natural killer cells associated with impaired cytokine network in the secretory endometrium of infertile PCOS women 92
Survivin gene-expression and splicing isoforms in oral squamous cell carcinoma 92
Expression profiling of key-genes in oral carcinogenesis. Assessment of real time PCR analysis in the context of the cancer stem cell theory 92
Expression of poly(ADP-ribose) polymerase in bone regeneration. 92
TLR4 down-regulation identifies high risk HPV infection and integration in head and neck squamous cell carcinomas. 92
Bladder Metastases from Lung Cancer: Clinical and Pathological Implications: A Systematic Review 92
Standardization of urine and saliva analysis by surface enhanced Laser desorption/ionization time of flight mass spectometry (SELDI-TOF-MS) 91
Correlazione tra espressione di proteine chromosomal passenger e parametri clinico-prognostici nei pazienti affetti da carcinoma squamoso del cavo orale. 91
Il linfangioma multicistico del mesentere dell'adulto 91
Adenocarcinoma NOS of The Maxillary Sinus: Clinical and Histopathological Features with Therapeutic Considerations 91
Gastric carcinoma: histopathology, immunocytochemistry and variations of nucleolar organizer regions (AgNORs). 90
SINDROME DI MORRIS: STUDIO MORFOMETRICO DEL DIDIMO E INDAGINE GENEALOGICA DI 6 CASI. 90
Alterazioni epigenetiche nel cancro orale: studio dei geni hMLH1, CFH1, CDKN2A, MGMT mediante Methylation Specific PCR (MSP) 90
A case of ovarian psammocarcinoma associated with endometrioid cysts: a morphological and immunohistochemical study. 90
RAS/BRAF mutational status in familial non-medullary thyroid carcinomas: A retrospective study 90
A new possibility to fill up peripheral nerve gaps up to 2 cm using a hyaluronic acid tubes: an experimental study 90
THE ROLE OF LIPOFILLING IN RECONSTRUCTIONS WITH DERMAL REGENERATION TEMPLATE: CLINICAL AND HISTOLOGICAL ASSESSMENT 90
Immunohistochemical characterization of germ cell tumors of the testis. 90
Analytical Morphometry in diagnostic pathology: upper degree polynomials and Fourier harmonic analysis in Infertility. 89
Sarcoma di Kaposi con localizzazione digiunale: Presentazione di un caso 89
Toll-like receptor 4 expression in the epithelium of inflammatory periapical lesions. An immunohistochemical study 89
Inflammatory Fibroid Polyp of the Rectum. 89
Colorectal carcinoma and its precursors: role of argyrophilic nucleolar organizer regions (AgNORs). 88
Elevati livelli di survivina e p-survivina si correlano alla espressione di p-34cdc2 e ciclina B1 nel carcinoma orale: possibili implicazioni diagnostico-terapeutiche 88
Epigenetic fingerprint in endometrial carcinogenesis: the hypothesis of a uterine field cancerization. 88
Double demonstration of oncogenic high risk human papilloma virus DNA and HPV-E7 protein in oral cancers. 88
Adenocarcinoma nos of the maxillary sinus: a very troubling diagnosis in an unusual site. 87
Large oral soft tissue metastasis from anaplastic carcinoma of the lung mimicking a primitive malignancy: case report and brief review of the literature 86
Up-regulation of endocrine gland-derived vascular endothelial growth factor in papillary thyroid cancers displaying infiltrative patterns, lymph node metastases, and BRAF mutation. 86
Pospho-protein-runx-2 expression is a prognostic marker of metastatic prostate carcinoma. 86
Long-term results of radical surgery and adjuvant radiotherapy in a case of primary malignant fibrous histiocytoma of the kidney 86
Human epidermal growth factor receptor 2 expression is more important than Bacillus Calmette Guerin treatment in predicting the outcome of T1G3 bladder cancer 86
Histochemical study of rabbit duodenal mucosa carried out using lectins. 85
OP005: Oral cancer and epigenetics: An in vitro study on 298 micro-RNA and future perspectives 85
Analisi dell’espressione di p120ctn in linee cellulari di carcinoma squamocellulare del cavo orale. 84
TRAP1 controls cell cycle G2–M transition through the regulation of CDK1 and MAD2 expression/ubiquitination 84
Double demonstration of oncogenic HPV DNA and HPV-E7 protein in 8.57% of oral cancers. Preliminary report 83
TRAP1 controls cell cycle progression through the regulation of CDK1 and MAD2 expression/ubiquitination in human breast, colon and lung carcinomas. 83
TRAP1 controls cell cycle G2-M transition through the regulation of CDK1 and MAD2 expression/ubiquitination 83
Cyclooxygenase-2 expression in oral squamous cell carcinoma. 82
Pentraxin 3: A Novel Biomarker for Predicting Progression from Prostatic Inflammation to Prostate Cancer. 82
Malignant large cell calcifying Sertoli cell tumor of the testis (LCCSCTT). Report of a case in an elderly man and review of the literature 81
Novel virus other than HPV 16 in laryngeal cancer: a case report with an innovative molecular virology profile 81
The role of geminin, a DNA replication factor in oral squamous cell carcinoma. Preliminary report of a tissue microarray based immunohistichemical study 79
Expression of mitotic kinases phospho-aurora A and aurora B correlates with clinical and pathological parameters in bladder neoplasms. 79
[Argyrophilic nucleolar organizer regions (AgNORs) as malignancy biomarkers in colorectal neoplasms] 79
Noninfiltrative anesthesia for transrectal prostate biopsy: A randomized prospective study comparing lidocaine-prilocaine cream and lidocaine-ketorolac gel 79
Anal melanoma. A case report.1989;19(4):401-4. 78
Studio sul grado di aneuploidizzazione dei carcinomi squamosi del cavo orale 78
Tumor infiltrating lymphocytes in uveal melanoma: a link with clinical behavior?. 77
Cyclooxygenase isozymes in oral squamous cell carcinoma: a real-time RT-PCR study with clinic pathological correlations. 77
Hyaluronic acid nerve guide for peripheral nerve injury repair up to 2cm 77
Saliva analysis by Surface Enhanced laser Desorption/Ionization Time of Flight Mass Spectrometry (SELDI-TOF/MS): from sample collection to data analysis 76
Totale 9.754
Salva come PNG Salva come JPEG
Categoria #
all - tutte 90.635
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 90.635
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020329 0 0 0 0 0 0 0 0 0 0 287 42
2020/20211.686 256 9 228 11 236 104 263 60 264 247 5 3
2021/20221.250 214 5 33 16 88 23 42 81 145 198 72 333
2022/20234.536 406 191 191 252 238 390 18 340 2.327 29 75 79
2023/2024859 139 40 32 29 74 321 29 47 2 13 8 125
2024/20252.593 210 66 119 106 118 431 219 167 837 269 51 0
Totale 17.572